Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer.

Yaghobi Joybari A, Azadeh P, Babaei S, Hosseini Kamal F.

Pathol Oncol Res. 2019 Feb 2. doi: 10.1007/s12253-019-00587-3. [Epub ahead of print]

PMID:
30712194
2.

Developing a WebGIS for Geo-Visualization of Cancer.

Khoshabi M, Taleai M, Motlagh A, Hosseini Kamal F.

Iran J Cancer Prev. 2016 Apr 24;9(2):e3910. doi: 10.17795/ijcp-3910. eCollection 2016 Apr.

3.

Cetuximab Plus Various Chemotherapy Regimens for Patients with KRAS Wild-Type Metastatic Colorectal Cancer.

Azadeh P, Mortazavi N, Tahmasebi A, Hosseini Kamal F, Novin K.

Chemotherapy. 2016;61(1):51-6. doi: 10.1159/000440693. Epub 2015 Nov 4.

PMID:
26528862
4.

Attitude of cancer patients toward diagnosis disclosure and their preference for clinical decision-making: a national survey.

Motlagh A, Yaraei N, Mafi AR, Hosseini Kamal F, Yaseri M, Hemati S, Shahbazian H, Sedighi AA, Khodabakhshi R, Taghizadeh A, Ansari J, Seyednejad F, Khanduzi R, Mojir Sheibani K, Azadeh P, Emranpour MH, Mosalei A, Vojdani S, Nazari AM, Nazarimenesh L, Fazl-Alizadeh A, Akbari ME.

Arch Iran Med. 2014 Apr;17(4):232-40. doi: 014174/AIM.004.

Supplemental Content

Loading ...
Support Center